İzmir Suat Seren Chest Disease Training & Research Hospital ( Site 0701)

Izmir 35110

1 studies enrolling now · 1 studies all time

What they study most

Lung Neoplasm Malignant

Studies at this site

• Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) — Recruiting now